Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,446,676
+$10,091,572 QoQ
Shares Held
173,137
+46.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$76,375
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $1,093,630,705 across 9 Drug Manufacturers - General names. NVS ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
715,082 | $657,710,971 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,203,665 | $194,302,282 | |
| 3 | AZN |
Astrazeneca PLC
|
382,048 | $75,347,506 | |
| 4 | AMGN |
Amgen Inc
|
147,488 | $51,893,652 | |
| 5 | BIIB |
Biogen Inc.
|
212,921 | $39,034,806 | |
| 6 | GSK |
GSK plc
|
548,222 | $30,256,372 | |
| 7 | NVS |
Novartis AG
This page
|
173,137 | $26,446,676 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
121,052 | $16,871,017 |
All Filings in NVS
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,446,676 | 173,137 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $76,375 | 500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $16,355,104 | 118,627 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $303,314 | 2,200 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $27,574 | 200 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $25,648 | 200 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $384,720 | 3,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $24,297,248 | 189,467 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $447,737 | 3,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $48,404 | 400 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $245,256 | 2,200 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $312,144 | 2,800 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $4,428,320 | 39,723 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $97,310 | 1,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $61,750,395 | 634,574 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $311,392 | 3,200 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $23,004 | 200 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $18,190,873 | 158,154 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $195,534 | 1,700 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $18,681,920 | 175,483 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $70,585,041 | 729,712 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,764,980 | 344,310 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,998,598 | 117,795 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $20,765,663 | 205,784 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $14,980,049 | 165,124 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,770,641 | 115,388 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,683,611 | 185,539 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,879,690 | 44,213 | Shares | Sole | 2022-05-09 | |
| 2021-09-30 | $8,435,116 | 103,144 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,509,397 | 104,224 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $231,308 | 2,706 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $6,014,588 | 69,165 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,507,313 | 17,258 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||